State of Wisconsin Investment Board’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

State of Wisconsin Investment Board’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,110	Closed	-$525K	–	2895
2022 Q1	$525K	Buy	+2,110	New	+$333K	﹤0.01%	1822
2021 Q2	–	Sell	-1,417	Closed	-$376K	–	2185
2021 Q1	$376K	Hold	1,417	–	–	﹤0.01%	1681
2020 Q4	$522K	Buy	+1,417	New	+$406K	﹤0.01%	1521
2020 Q1	–	Sell	-1,173	Closed	-$524K	–	1746
2019 Q4	$524K	Hold	1,173	–	–	﹤0.01%	1429
2019 Q3	$361K	Buy	+1,173	New	+$381K	﹤0.01%	1421

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wisconsin Investment Board's EIGR Position: Q2 2022 in Review

State of Wisconsin Investment Board sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2022, closing a stake of 2,110 shares — an estimated $525K sold.

State of Wisconsin Investment Board first reported a position in EIGR in Q3 2019 and held it in 5 quarters. The position peaked at $525K in Q1 2022. 91 funds tracked by Wall St. Rank hold EIGR as of Q2 2022.

State of Wisconsin Investment Board reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
State of Wisconsin Investment Board sold 2,110 Eiger BioPharmaceuticals, Inc. shares in Q2 2022, an estimated $525K.
State of Wisconsin Investment Board first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2019 and held it in 5 quarters.
State of Wisconsin Investment Board's Eiger BioPharmaceuticals, Inc. position peaked at $525K in Q1 2022.
91 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2022, filed 15 Aug 2022.